ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2141

Quantitative Nailfold Video Capillaroscopy Parameters Correlate with Dermatomyositis Activity and Damage

Hans Prakash1, Diego Song1, Daniel Lichy1, Pranay Rao2, Mina Jain3, Joseph Shrader3, Frederick W Miller4, Adam Schiffenbauer5, Alexander Gorbach1 and Lisa G Rider5, 1National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 2National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, bethesda, MD, 3Rehabilitation Medicine Department, National Institutes of Health, Bethesda, MD, 4Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, 5Environmental Autoimmunity Grp, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Activity score, Assessment, dermatomyositis, juvenile dermatomyositis and nailfold capillaroscopy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

To assess microvascular structure and function in patients with adult dermatomyositis (DM) and juvenile dermatomyositis (JDM), we have designed and built a mobile, high-resolution Nailfold Video Capillaroscopy (NFVC) installation for clinical use, and correlated the results with both laboratory and clinical measures in patients.

Methods:

We quantified nailfold capillary features in patients with DM (n=28) and JDM (n=17) with median age of 16.1 yrs (IQR 10.5 – 42.8) and median disease duration of 2.95 yrs (IQR 1.1 – 10.2) (74% females and 59% Caucasian) and healthy control subjects (n=18) with similar demographics. Capillary structural markers, including capillary density, tortuosity, interlimb distance, and functional markers, including local blood velocity in arterial (BVA) and venous (BVV) segments of capillaries, were measured. Left ring finger imaging of the nailfold area was performed with a motorized stereomicroscope (Leica M205C) equipped with a video camera (Hamamatsu ORCA-Flash4.0) at 25x overall magnification, providing 1 µm resolution and up to 100 Hz acquisition rate. Spearman rank correlation coefficients and p-values were calculated to determine correlations between NFVC markers and clinical data.

Results:

Capillary density (p<0.01), BVA (p < 0.05), and BVV (p < 0.05) are significantly lower in patients with DM and JDM than healthy subjects. Interlimb distance and capillary tortuosity were higher in DM or JDM than healthy controls (p<0.01). Capillary density and capillary interlimb distance (r= -0.65, p <0.001) correlated inversely, and BVA and BVV strongly correlated (r=0.95, p <0.001). There were no significant differences in any of these NFVC parameters between DM and JDM. NFVC markers correlated with myositis activity and damage measures and laboratory data from the combined DM/JDM group. Skin disease activity scores (DAS skin) negatively correlated with capillary density (r= -0.46, p <0.01) and positively with capillary interlimb distance (r=0.48, p<0.01). Extramuscular Myositis Disease Activity Assessment Tool (MDAAT) correlated with capillary tortuosity (r=0.35, p<0.05). Gastrointestinal (GI) MDAAT scores correlated negatively with BVA and BVV (r= -0.62 – -0.58, p<0.01), whereas manual muscle testing correlated with BVA and BVV (r=0.50-0.53, p<0.05). Among laboratory measures, ESR correlated with interlimb distances (r=0.41, p < 0.05) and negatively correlated with BVA and BVV (r= -0.47 – -0.48, p<0.05), and white blood cell count correlated with capillary tortuosity (r=0.55, p <0.001). Muscle enzymes and von Willebrand factor related antigen levels did not correlate with NFVC parameters. Among damage measures, MD global damage and muscular and skeletal damage in the Myositis Damage Index (MDI) correlated with capillary tortuosity (r=0.36 – 0.37, p<0.05), and GI MDI scores correlated negatively with BVA and BVV (r= -0.57 – -0.63, p<0.05).

Conclusion:

Structrual and functional NFVC markers correlate with disease activity and damage measures in muscle and extramuscular organs in children and adults with DM. Functional parameters of NFVC, including tortuosity and blood velocity, reveal new dimensions of the utility of NFVC in myositis assessment.


Disclosure: H. Prakash, None; D. Song, None; D. Lichy, None; P. Rao, None; M. Jain, None; J. Shrader, None; F. W. Miller, None; A. Schiffenbauer, None; A. Gorbach, None; L. G. Rider, None.

To cite this abstract in AMA style:

Prakash H, Song D, Lichy D, Rao P, Jain M, Shrader J, Miller FW, Schiffenbauer A, Gorbach A, Rider LG. Quantitative Nailfold Video Capillaroscopy Parameters Correlate with Dermatomyositis Activity and Damage [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/quantitative-nailfold-video-capillaroscopy-parameters-correlate-with-dermatomyositis-activity-and-damage/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-nailfold-video-capillaroscopy-parameters-correlate-with-dermatomyositis-activity-and-damage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology